<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="79049">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02059746</url>
  </required_header>
  <id_info>
    <org_study_id>AOI/2013/RdeT</org_study_id>
    <secondary_id>EGY/TDG/AR141876</secondary_id>
    <nct_id>NCT02059746</nct_id>
  </id_info>
  <brief_title>Perineal Consequences of Twin Pregnancies According to Mode of Delivery</brief_title>
  <acronym>JUMODA-CP</acronym>
  <official_title>Perineal Consequences of Twin Pregnancies According to Mode of Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <authority>France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an ancillary study to the &quot;JUMODA&quot; (National Prospective and Comparative Study on
      the Mode of Delivery of Twins) study: please see NCT01987063.

      The main objective of this study is to investigate the role of the mode of delivery (vaginal
      versus cesarean) as a risk factor for the occurrence of urinary incontinence at 3 months
      post-delivery in primiparous women delivering twins after 34 weeks of pregnancy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives of this study are to compare the following elements between
      primiparous mothers giving birth to twins vaginally versus by caesarean section after 34
      weeks of pregnancy (comparisons will be made at 3 months ant at 12 months post-partum):

      A. Diagnosis, type and severity of urinary incontinence via the ICIQ-UI questionnaire

      B. Urinary, anorectal and perineal symptoms via the PFDI-20 questionnaire

      C. Quality of life related to urinary, anorectal and pelvic floor symptoms via the PFIQ-7
      questionnaire

      D. Sexuality via the PISQ-12 questionnaire

      E. General quality of life via the SF-12 questionnaire
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Presence/absence of urinary incontinence</measure>
    <time_frame>3 months post-partum</time_frame>
    <safety_issue>No</safety_issue>
    <description>Defined by a response of 1 to 5 on the first question of the ICIQ-UI questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The ICIQ-UI questionnaire</measure>
    <time_frame>3 months post-partum</time_frame>
    <safety_issue>No</safety_issue>
    <description>ICIQ-Urinary Incontinence Form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The PFDI-20 questionnaire</measure>
    <time_frame>3 months post-partum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The ICIQ-UI questionnaire</measure>
    <time_frame>12 months post-partum</time_frame>
    <safety_issue>No</safety_issue>
    <description>ICIQ-Urinary Incontinence Form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The PFDI-20 questionnaire</measure>
    <time_frame>12 months post-partum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The PFIQ-7 questionnaire</measure>
    <time_frame>3 months post-partum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The PFIQ-7 questionnaire</measure>
    <time_frame>12 months post-partum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The PISQ-12 questionnaire</measure>
    <time_frame>3 months post-partum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The PISQ-12 questionnaire</measure>
    <time_frame>12 months post-partum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The SF-12 questionnaire</measure>
    <time_frame>3 months post-partum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The SF-12 questionnaire</measure>
    <time_frame>12 months post-partum</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2160</enrollment>
  <condition>Pregnancy, Multiple</condition>
  <arm_group>
    <arm_group_label>Vaginal birth</arm_group_label>
    <description>Patients in the group give birth vaginally.
Intervention: Questionnaires sent by mail</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cesaren section</arm_group_label>
    <description>Patients in this group give birth via cesarean section.
Intervention: Questionnaires sent by mail</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires sent by mail</intervention_name>
    <description>The questionnaires necessary for the study are mailed to patients at 3 and 12 months post-partum.</description>
    <arm_group_label>Vaginal birth</arm_group_label>
    <arm_group_label>Cesaren section</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This is an ancillary  to the &quot;JUMODA&quot; study (please see NCT01987063). The study population
        is composed of primiparous women pregnant with twins (non primiparous patients in the
        study JUMODA will therefore not includable), giving birth after 34 weeks to 2 live
        children.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must have given his/her informed and signed consent

          -  The patient must be insured or beneficiary of a health insurance plan

          -  The patient is available for 12 months of follow-up following delivery

          -  The patient was included in the JUMODA study

          -  Primiparous

          -  Birth of 2 live children after 34 weeks of pregnancy

        Exclusion Criteria:

          -  Adult patient under guardianship

          -  Patient under judicial protection

          -  It proves impossible to correctly inform the patient

          -  Birth occurring before 34 weeks of pregnancy

          -  Birth not resulting in 2 living children
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Renaud de Tayrac, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Renaud de Tayrac, MD, PhD</last_name>
    <phone>+33.(0)4.66.68.32.16</phone>
    <email>renaud.detayrac@chu-nimes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carey Suehs, PhD</last_name>
    <phone>+33.(0)4.66.68.67.88</phone>
    <email>carey.suehs@chu-nimes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU de Montpellier - Hôpital Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHRU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 9</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Renaud de Tayrac, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent Letouzey, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 4, 2014</lastchanged_date>
  <firstreceived_date>February 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cesarean section</keyword>
  <keyword>vaginal birth</keyword>
  <keyword>twins</keyword>
  <keyword>urinary incontinence</keyword>
  <keyword>sexuality</keyword>
  <keyword>quality of life</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
